Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Clinical trial NCT00398138 · COMPLETED

Trial details

NCT number: NCT00398138
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia Lung Cancer Malignant Mesothelioma Myelodysplastic Syndromes Primary Peritoneal Cavity Cancer

Start date: 2006-10-01
Primary completion: 2009-06-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.